tranexamic acid has been researched along with B16 Melanoma in 1 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakashima, S | 1 |
| Oda, Y | 1 |
| Nakamura, S | 1 |
| Liu, J | 1 |
| Onishi, K | 1 |
| Kawabata, M | 1 |
| Miki, H | 1 |
| Himuro, Y | 1 |
| Yoshikawa, M | 1 |
| Matsuda, H | 1 |
1 other study available for tranexamic acid and B16 Melanoma
| Article | Year |
|---|---|
Inhibitors of melanogenesis in B16 melanoma 4A5 cells from flower buds of Lawsonia inermis (Henna).
Topics: Animals; Antifibrinolytic Agents; Cell Line, Tumor; Cell Proliferation; Flavonoids; Flowers; Humans; | 2015 |